Close Menu

NEW YORK (GenomeWeb News) – The GenomeWeb Daily News Index slid about 2 percent in August, mirroring the decline in the broader market.

During the month, 19 of the 30 firms comprising the Index saw their month-over-month share prices retreat, led by Nanosphere, which was down almost 34 percent. Vermillion (-20 percent), NanoString Technologies (-16 percent) and Exact Sciences (-16 percent) were also down significantly during the month.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Guardian reports that some UK physicians are calling for increased regulation of direct-to-consumer genetic tests.

US tax agency says 23andMe's genetic health test can be claimed as a medical expense for tax purposes, the Wall Street Journal reports.

Two Democratic lawmakers argue at USA Today that independent science is under attack by the Trump Administration.

In PLOS this week: networks of genes co-expressed in depression, role of minichromosome maintenance genes in lung adenocarcinoma, and more.